Sentonix is a pharmaceutical company that offers immuno-therapy service for cancer treatment.
Sentonix's investors include Catalio Capital Management.
Sentonix is headquartered in Arlington, United States.
Sentonix is a pharmaceutical company that offers immuno-therapy service for cancer treatment.
Sentonix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sentonix — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/sentonix. Accessed August 14, 2026.
VCBacked. (2025). Sentonix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sentonix
{{cite web |title=Sentonix — Funding & Investors |url=https://www.vcbacked.co/company/sentonix |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated